期刊
STEM CELLS TRANSLATIONAL MEDICINE
卷 1, 期 12, 页码 855-865出版社
ALPHAMED PRESS
DOI: 10.5966/sctm.2012-0093
关键词
Induced pluripotent stem cells; Endothelial cell; Progenitor cells; Reprogramming; Direct cell conversion
资金
- British Heart Foundation [RG/08/002/24718]
- Medical Research Council [G1000847, 85198]
- Wellcome Trust [098051, 090660/Z/09/Z]
- Fondation Leducq
- Cambridge Cardiovascular Consortium
- Cambridge NIHR Biomedical Research Centre
- Cambridge Stem Cell Institute
- Pfizer
- Academy of Medical Sciences (AMS) [AMS-SGCL5-Toshner] Funding Source: researchfish
- British Heart Foundation [FS/12/39/29653, RG/08/002/24718] Funding Source: researchfish
- Medical Research Council [G0800784, G1000847] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10174] Funding Source: researchfish
- Wellcome Trust [090660/Z/09/Z] Funding Source: Wellcome Trust
- MRC [G0800784, G1000847] Funding Source: UKRI
Induced pluripotent stem cells (iPSCs) have the potential to generate patient-specific tissues for disease modeling and regenerative medicine applications. However, before iPSC technology can progress to the translational phase, several obstacles must be overcome. These include uncertainty regarding the ideal somatic cell type for reprogramming, the low kinetics and efficiency of reprogramming, and karyotype discrepancies between iPSCs and their somatic precursors. Here we describe the use of late-outgrowth endothelial progenitor cells (L-EPCs), which possess several favorable characteristics, as a cellular substrate for the generation of iPSCs. We have developed a protocol that allows the reliable isolation of L-EPCs from peripheral blood mononuclear cell preparations, including frozen samples. As a proof-of-principle for clinical applications we generated EPC-iPSCs from both healthy individuals and patients with heritable and idiopathic forms of pulmonary arterial hypertension. L-EPCs grew clonally; were highly proliferative, passageable, and bankable; and displayed higher reprogramming kinetics and efficiencies compared with dermal fibroblasts. Unlike fibroblasts, the high efficiency of L-EPC reprogramming allowed for the reliable generation of iPSCs in a 96-well format, which is compatible with high-throughput platforms. Array comparative genome hybridization analysis of L-EPCs versus donor-matched circulating monocytes demonstrated that L-EPCs have normal karyotypes compared with their subject's reference genome. In addition, >80% of EPC-iPSC lines tested did not acquire any copy number variations during reprogramming compared with their parent L-EPC line. This work identifies L-EPCs as a practical and efficient cellular substrate for iPSC generation, with the potential to address many of the factors currently limiting the translation of this technology. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:855-865
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据